Outcomes of therapy-related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation.
Ram Vasudevan NampoothiriArjun Datt LawWilson LamCarol ChenZeyad Al-ShaibaniDavid LoachFotios V MichelisDennis Dong Hwan KimJonas MattssonRajat KumarJeffrey Howard LiptonAuro ViswabandyaPublished in: European journal of haematology (2020)
Allogeneic HSCT outcomes in t-ALL were comparable to HSCT outcomes in de novo ALL. Multicenter studies with more patients and longer follow-up may provide factors affecting outcome and survival.
Keyphrases
- stem cell transplantation
- high dose
- acute lymphoblastic leukemia
- hematopoietic stem cell
- bone marrow
- newly diagnosed
- end stage renal disease
- ejection fraction
- low dose
- clinical trial
- cross sectional
- allogeneic hematopoietic stem cell transplantation
- mesenchymal stem cells
- free survival
- smoking cessation
- drug induced